1. In vitro comparison of 3D printed polylactic acid/hydroxyapatite and polylactic acid/bioglass composite scaffolds: Insights into materials for bone regeneration
- Author
-
Egidijus Simoliunas, Migle Kalvaityte, Ieva Gendviliene, Milda Alksne, Vygandas Rutkunas, Virginija Bukelskiene, Janis Locs, and Ieva Rinkunaite
- Subjects
3d printed ,Artificial bone ,Ceramics ,Bone Regeneration ,Polyesters ,Composite number ,Biomedical Engineering ,02 engineering and technology ,Bioceramic ,Biomaterials ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,stomatognathic system ,Polylactic acid ,Dental pulp stem cells ,Animals ,Humans ,Bone regeneration ,Cell Proliferation ,Tissue Scaffolds ,Chemistry ,technology, industry, and agriculture ,030206 dentistry ,respiratory system ,equipment and supplies ,021001 nanoscience & nanotechnology ,In vitro ,Rats ,Durapatite ,Chemical engineering ,Mechanics of Materials ,Printing, Three-Dimensional ,lipids (amino acids, peptides, and proteins) ,0210 nano-technology - Abstract
3D printing of polylactic acid (PLA) and hydroxyapatite (HA) or bioglass (BG) bioceramics composites is the most promising technique for artificial bone construction. However, HA and BG have different chemical composition as well as different bone regeneration inducing mechanisms. Thus, it is important to compare differentiation processes induced by 3D printed PLA + HA and PLA + BG scaffolds in order to evaluate the strongest osteoconductive and osteoinductive properties possessing bioceramics. In this study, we analysed porous PLA + HA (10%) and PLA + BG (10%) composites' effect on rat's dental pulp stem cells fate in vitro. Obtained results indicated, that PLA + BG scaffolds lead to weaker cell adhesion and proliferation than PLA + HA. Nevertheless, osteoinductive and other biofriendly properties were more pronounced by PLA + BG composites. Overall, the results showed a strong advantage of bioceramic BG against HA, thus, 3D printed PLA + BG composite scaffolds could be a perspective component for patient-specific, cheaper and faster artificial bone tissue production.
- Published
- 2019